feed,title,long_url,short_url
BioRxiv,Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines,https://www.biorxiv.org/content/10.64898/2026.02.04.703921v1?rss=1,
